Skip to main content

Peer Review reports

From: Combined PD-1/PD-L1 and tumor-infiltrating immune cells redefined a unique molecular subtype of high-grade serous ovarian carcinoma

Original Submission
7 Aug 2021 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 Oct 2021 Reviewed Reviewer Report
10 Nov 2021 Reviewed Reviewer Report
10 Dec 2021 Author responded Author comments - Wei Jia
Resubmission - Version 3
10 Dec 2021 Submitted Manuscript version 3
Publishing
20 Dec 2021 Editorially accepted
13 Jan 2022 Article published 10.1186/s12864-021-08265-y

You can find further information about peer review here.

Back to article page